troxacitabine has been researched along with mebendazole in 1 studies
| Studies (troxacitabine) | Trials (troxacitabine) | Recent Studies (post-2010) (troxacitabine) | Studies (mebendazole) | Trials (mebendazole) | Recent Studies (post-2010) (mebendazole) |
|---|---|---|---|---|---|
| 72 | 17 | 2 | 2,089 | 184 | 438 |
| Protein | Taxonomy | troxacitabine (IC50) | mebendazole (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 5 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 5.5667 | |
| Calmodulin-domain protein kinase 1 | Toxoplasma gondii | 0.67 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
1 other study(ies) available for troxacitabine and mebendazole
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |